MyFinsight
Home
Blog
About
Contact
Download
Download image
Wholesaler chargebacks,
discounts and fees
-$11M
(-150.00%↓ Y/Y)
Net loss
-$1,343M
(-38.31%↓ Y/Y)
Gross product sales
$350M
(233.33%↑ Y/Y)
Total product sales
provision adjustments
-$2M
(-110.53%↓ Y/Y)
Returns, rebates and
other fees
$9M
(400.00%↑ Y/Y)
Loss before income
taxes
-$1,334M
(-38.38%↓ Y/Y)
Provision for income taxes
$9M
(28.57%↑ Y/Y)
Interest income
$72M
(-20.00%↓ Y/Y)
Product Sales
$352M
(309.30%↑ Y/Y)
Product And Service
Other
$37M
(68.18%↑ Y/Y)
Loss from operations
-$1,388M
(-32.19%↓ Y/Y)
Total revenue
$389M
(260.19%↑ Y/Y)
Other expense, net
-$18M
(-350.00%↓ Y/Y)
Total operating
expenses
$1,777M
(53.45%↑ Y/Y)
Cost of sales
$955M
(961.11%↑ Y/Y)
Research and development
$649M
(-24.18%↓ Y/Y)
Selling, general and
administrative
$173M
(-18.40%↓ Y/Y)
Back
Back
Income Statement
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)
Master Final R&D Day 2021 Slides (09
source: myfinsight.com
Moderna, Inc. (MRNA)